MAPT and Alzheimer disease: It has also been suggested that homeostatic genetic signatures displayed by the repopulated microglia might prevent its switching to a disease-associated microglia phenotype, essential to limit Aβ plaque–mediated tau pathogenesis in Alzheimer’s disease (AD) (Casali et al., 2020; Gratuze et al., 2021).